Tamara McGrillen | Head of Investor Relations |
Geert Cauwenbergh | President and Chief Executive Officer |
Caitlin Kontulis | Principal Accounting Officer |
Gerrit Dispersyn | Chief Development Officer |
Julian Harrison | H.C. Wainwright & Co. |
Anita Dushyanth | Zacks Small Capital Research |
Good day, ladies and gentlemen, and welcome to today's webcast entitled RXi Pharmaceuticals Second Quarter 2018 Financial Results Earnings Call. Today's call is being recorded. At this time, it is my pleasure to turn the floor over to the Head of Investor Relations for RXi, Tamara McGrillen. Ma'am, the floor is yours.
Thank you, operator, and good afternoon, ladies and gentlemen, and thank you for participating on our call today.